Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide)		Trials
(pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide)		Recent Studies (post-2010) (pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide)
9,1561875524700

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ezra, D; Faden, AI; Feuerstein, G; Lux, WE; Snyder, F1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pyro(l-alpha-aminoadipyl)-l-histidyl-l-thiazolidine-4-carboxamide

ArticleYear
Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
    Circulatory shock, 1984, Volume: 13, Issue:3

    Topics: Animals; Blood Pressure; Guinea Pigs; Hypotension; Male; Naloxone; Platelet Activating Factor; Thiazolidines; Thyrotropin-Releasing Hormone; Time Factors

1984